Q1 EPS Estimates for Tenet Healthcare Cut by Leerink Partnrs

Tenet Healthcare Co. (NYSE:THC) – Investment analysts at Leerink Partnrs dropped their Q1 2025 earnings per share estimates for Tenet Healthcare in a report released on Wednesday, February 12th. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings of $3.07 per share for the quarter, down from their previous forecast of $3.57. The consensus estimate for Tenet Healthcare’s current full-year earnings is $11.37 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q1 2025 earnings at $3.07 EPS, Q3 2025 earnings at $2.71 EPS, Q3 2025 earnings at $2.71 EPS, FY2025 earnings at $11.82 EPS, FY2025 earnings at $11.82 EPS, FY2026 earnings at $13.64 EPS, FY2026 earnings at $13.64 EPS, FY2027 earnings at $15.90 EPS and FY2027 earnings at $15.90 EPS.

A number of other equities analysts have also recently issued reports on THC. Barclays decreased their target price on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating on the stock in a report on Thursday, February 13th. UBS Group boosted their price objective on Tenet Healthcare from $197.00 to $217.00 and gave the stock a “buy” rating in a report on Wednesday, October 30th. KeyCorp decreased their target price on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Truist Financial reduced their price target on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Royal Bank of Canada lifted their price objective on shares of Tenet Healthcare from $174.00 to $183.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $163.19.

Tenet Healthcare Trading Up 1.5 %

Tenet Healthcare stock opened at $135.30 on Monday. Tenet Healthcare has a 1 year low of $88.98 and a 1 year high of $171.20. The firm’s 50 day moving average price is $133.09 and its two-hundred day moving average price is $147.95. The firm has a market cap of $12.87 billion, a price-to-earnings ratio of 4.34, a price-to-earnings-growth ratio of 0.63 and a beta of 2.05. The company has a debt-to-equity ratio of 2.35, a quick ratio of 1.52 and a current ratio of 1.58.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%.

Hedge Funds Weigh In On Tenet Healthcare

Several hedge funds have recently bought and sold shares of the business. Neo Ivy Capital Management acquired a new position in shares of Tenet Healthcare during the 4th quarter valued at about $2,773,000. Vise Technologies Inc. grew its holdings in Tenet Healthcare by 28.4% during the fourth quarter. Vise Technologies Inc. now owns 1,613 shares of the company’s stock valued at $204,000 after purchasing an additional 357 shares during the last quarter. MidWestOne Financial Group Inc. lifted its stake in shares of Tenet Healthcare by 6.7% in the fourth quarter. MidWestOne Financial Group Inc. now owns 11,822 shares of the company’s stock worth $1,492,000 after buying an additional 744 shares during the last quarter. PharVision Advisers LLC bought a new stake in shares of Tenet Healthcare during the 4th quarter worth $359,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Tenet Healthcare by 18.9% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 264,055 shares of the company’s stock worth $33,332,000 after acquiring an additional 42,025 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.